Networks of fixed topology are used to summarize the collective understanding of the flow of signaling information within a cell (i.e., canonical signaling networks). Moreover, these canonical signaling networks are used to interpret how observed oncogenic changes in protein activity or expression alter information flow in cancer cells. However, creating a novel branch within a signaling network (i.e., a noncanonical edge) provides a mechanism for a cell to acquire the hallmark characteristics of cancer. The objective of this study was to assess the existence of a noncanonical edge within a receptor tyrosine kinase (RTK) signaling network based upon variation in protein expression alone, using a mathematical model of the early signaling events associated with epidermal growth factor receptor 1 (ErbB1) signaling network as an illustrative example. The abundance of canonical protein-RTK complexes (e.g., growth factor receptor bound protein 2-ErbB1 and Src homology 2 domain containing transforming protein 1-ErbB1) were used to establish a threshold that was correlated with ligand-dependent changes in cell proliferation. Given the available data, the uncertainty associated with this threshold was estimated using an empirical Bayesian approach. Using the variability in protein expression observed among a collection of breast cancer cell lines, this model was used to assess whether a noncanonical edge (e.g., Irs1-ErbB1) exceeds the threshold and to identify cell lines where this noncanonical edge is likely to be observed. Taken together, the simulations suggest that the topology of signal transduction networks within cells is influenced by quantitative parameters, such as protein expression and binding affinity. Moreover, forming this noncanonical pathway was not due solely to overexpression of the cell surface receptor but was influenced by overexpression of all members of the multiprotein complex. Multivariate alterations in expression of signaling proteins in cancer cells may activate noncanonical pathways and may rewire the signaling network within a cell. Cancer Res; 70(5); 1773-82. ©2010 AACR.
Introduction
Cellular response to extracellular stimuli is governed by biochemical reactions that allow the transfer of information from the cell membrane to the nucleus and back (3) . The collective understanding of how information travels within a cell in response to a specific stimulus is summarized by a series of canonical signaling pathways (e.g., ref. 4) . These pathways can be computationally represented in a variety of forms, including graphs (e.g., ref. 5), directed graphs (e.g., ref. 6) , and chemical kinetic representations (e.g., refs. 7, 8) . Models based upon a chemical kinetic formalism have the best predictive power under novel conditions. However, the technical requirements for obtaining appropriate data to support the development of chemical kinetic models with increased biological realism can be prohibitive.
Alternative approaches have been developed to minimize these technical hurdles and to provide insight into the function of signaling networks. One approach is based upon metabolic control analysis (MCA; refs. 9, 10) to constrain the range of signaling trajectories (11) . However, a prerequisite of this approach is an understanding of the topology of the signaling network. The topology of a signaling network is composed of a series of nodes (i.e., proteins) and edges (i.e., the velocity of information flow due to protein-protein interactions). The topology of the signaling network corresponds to the ability of a cell to maintain the flow of information despite perturbations in the network (i.e., a robust cellular response; ref. 12) . It has been suggested that the robustness of a network, not the quantitative parameters (e.g., protein expression levels or kinetic rate constants), is one of the most important considerations for determining cellular response (13) . However, an emerging concept in oncology is that the topology of signaling networks becomes rewired in cancer (14) . These new edges create novel branches in the signaling network of cancer cells. The novel branches are called noncanonical pathways.
One of the challenging questions in the field of oncology is understanding how signaling pathways are altered due to
Quick Guide to Equations and Assumptions
The model focuses on the early signaling events associated with the receptor tyrosine kinase epidermal growth factor (EGF) receptor 1 (ErbB1). The model represents ErbB1 synthesis and degradation; EGF ligand binding to ErbB1; receptor dimerization and activation; activation of the signaling pathways associated with the binary interactions between ErbB1 + Src homology 2 domain containing transforming protein 1 (Shc), Shc + growth factor receptor bound protein 2 (Grb2), ErbB1 + Shc-Grb2, ErbB1 + Grb2, and Grb2 + son of sevenless (Sos); deactivation of ErbB1 following protein tyrosine phosphatase (PTP) + ErbB1 interactions; and dissociation of active Shc from ErbB1. The initial binding event associated with a hypothetical noncanonical pathway is represented by the binary interaction between ErbB1 + insulin receptor substrate 1 (Irs-1). A rankbased heuristic was used to constrain model size. The resulting model, composed of 20 nonlinear ordinary differential equations and one algebraic equation, is shown graphically in Fig. 1 and described in detail in Supplementary Tables S-I (Model  Variables) , S-III (Rate Laws for Reaction Network), S-IV (Set of Differential-Algebraic Equations), and S-V (Model Parameters).
Major Assumptions of the Model
• As this was an illustrative example, ErbB1-Irs-1 interaction is assumed to be the only potential noncanonical edge.
• The biological consequence associated with the formation of an absolute amount of multiprotein complex in a canonical context was assumed to be similar in a noncanonical context (i.e., if 1 nmol/L of canonical multiprotein complex elicits a functional response, then 1 nmol/L of a noncanonical multiprotein complex also elicits a functional response).
• Phosphorylation of different intracellular ErbB1-associated tyrosines was assumed to occur on a faster timescale that the observed dynamics (i.e., it was at pseudoequilibrium).
• Primary interactions between phosphorylated ErbB1 and intracellular signaling proteins were assumed to be competitive (this results in the algebraic equation).
• Differences in protein expression were assumed to be the only change among cellular models of breast cancer (i.e., rate parameters and protein-protein interaction energies were assumed to be constant).
• The sensitivity for quantifying protein expression by Western blot (i.e., detection limit and relationship between chemiluminescence and abundance) was assumed to be the same for ErbB1, Shc, Grb2, and Irs-1.
• The dynamics for signal activation in primary rat hepatocytes were assumed to be similar to normal human cells. In the absence of data, the predicted protein concentrations were assumed to be drawn from the lower end in the range of protein expression observed in the collection of breast cancer cell lines.
• Protein-protein interaction energies observed by Jones and colleagues (1) and Kaushansky and colleagues (2) were assumed to be similar to primary rat hepatocytes.
• Interaction energies between two proteins were assumed to be independent of the activation state of the intracellular signaling protein (e.g., phosphorylated Shc versus unphosphorylated Shc).
• Dissociation of multiprotein signaling complexes containing Sos were neglected due to the influence of macromolecular crowding on interaction energies.
• With the exception of implicit casitas B-lineage lymphoma proto-oncogene-mediated receptor downregulation and dephosphorylation of phosphorylated proteins by a virtual PTP, additional positive and negative feedback mechanisms were assumed to have negligible effect on the simulated dynamics.
• The association rate for Irs-1 binding to phosphorylated ErbB1 was assumed to be the same as Grb2 binding to phosphorylated ErbB1.
• The dose-dependent behavior of EGF-induced cell proliferation and protection from apoptosis are assumed to be different, whereby EGF-induced protection from apoptosis becomes saturated before EGF promotes cell proliferation.
• As bound receptors become internalized, downstream signaling events were assumed not to depend on location.
• Individual reactions were grouped into reaction classes, as defined by specific interactions between two protein motifs. Rate parameters were assigned to the reaction classes rather than specific reactions. pathologic changes in gene expression and protein modification. These alterations, related to the expression of a cells' genes, influence quantitative parameters associated with protein-protein interactions. Point mutations can change the affinity between proteins, such as between the tyrosine kinase inhibitor imatinib mesylate and its intracellular binding site (15) . Gene deletions may lead to the deletion of specific nodes within a signaling network (16) . Epigenetic changes, such as methylation patterns, can influence expression levels of proteins (17) . An increase in expression of a protein within a cell raises the issue of protein promiscuity (18) . Moreover, multiple changes can occur within a cell simultaneously (19) and among cells of a tumor (20, 21) . In summary, these cellular changes can cause abnormal expression of proteins involved in cellular signaling pathways, can change the individual contributions of specific signaling pathways, and can create new edges that are not considered "important" in normal cells. Thus, interpreting abnormal protein expression in the context of intracellular signaling is essential for understanding the molecular basis for cancer. However, the question posed in this study is: should abnormal protein expression be interpreted solely within the context of canonical signaling pathways?
Existing approaches for modeling receptor signaling pathways largely use the canonical signaling pathways as a basis for specifying the reaction network. The objective of this study was 2-fold: (a) to assess the plausibility of noncanonical signaling pathways and (b) to aid in selecting experimental Figure 1 . Schematic diagram of model developed for early ErbB1 signaling. A schematic diagram of the biochemical events represented in the mathematical model presented graphically using Systems Biology Graphical Notation (41) . The model represents ErbB1 synthesis and degradation; binding to EGF ligand; receptor dimerization and activation; activation of the signaling pathways associated with the binary interactions between ErbB1 + Shc, Shc + Grb2, ErbB1 + Grb2, and Grb2 + Sos; deactivation following PTP + ErbB1 interactions; and dissociation of active Shc. The initial binding event associated with a hypothetical noncanonical edge is represented by the interaction between ErbB1 + Irs-1.
conditions where noncanonical signaling may influence cellular response. To achieve these objectives, I calibrated and validated a kinetic model for the early signaling events associated with the epidermal growth factor (EGF) signaling network, a network linked to many different types of cancer (e.g., refs. [22] [23] [24] . Using this computational framework, thermodynamic information about protein-protein interactions and relative protein expression patterns, among cell lines that comprise an in vitro model for breast cancer, was integrated to predict the existence of a noncanonical edge of this receptor tyrosine kinase (RTK) signaling network and to identify specific cell lines for validation experiments.
Materials and Methods

Developing the Mathematical Model
The development of a mathematical model for describing the early signaling events via the epidermal growth factor receptor 1 (ErbB1) receptor was shaped by two primary considerations: (a) to represent the initial signaling events associated with a subset of canonical EGF signaling pathways and (b) to represent other signaling events that create noncanonical edges in signaling networks. To address these considerations, I focused on biochemical interactions that are centered on the ErbB1 receptor. The application of quantitative methods to the EGF signaling pathway was pioneered by Kholodenko and colleagues (8) and extended by many others (25) . In this work, the objectives of this study required the synthesis of a new mathematical model that incorporates elements of this prior art.
There are three components of developing a mathematical model for a reaction network. First, one must construct the topology of the reaction network (i.e., the series of biochemical interactions between reacting species). Once the reaction topology is specified, initial conditions must be specified for the variables that describe the evolution in the species concentrations as a function of time. Finally, one must select values for the reaction parameters that are consistent with the data selected for calibrating the model. Once calibrated, the predictive potential of the model can be shown by comparing simulated results against additional data not used in calibrating the model. In the following paragraphs, each of these components of the ErbB1 signaling network will be discussed in more detail.
Reaction network topology. Prediction of the functional signaling topology within cells is dependent on the availability of information regarding the protein expression levels and the protein-protein interaction energies. Given the limited information regarding these values, the mathematical model presented in this paper illustrates in generic terms on how this information may be combined to rationalize about how the functional signaling topology may change within different cancer cells. In addition, some biological detail, incorporated in other models of the EGF network, was not explicitly represented in the model to focus efforts on the primary signaling events that occur after receptor ligation. The resulting model, composed of 20 nonlinear ordinary differential equations and one algebraic equation, is shown graphically in Fig. 1 . In the interest of brevity, a detailed discussion of the rationale behind developing the model and the particular equations used can be found in Supplementary Data.
Model calibration. The resulting biochemical reaction network specifies a particular causal connectivity diagram between proteins (i.e., a set of coupled nonlinear differential algebraic equations). This connectivity diagram must be coupled with parameters for each reaction to simulate the concentration changes with time. The literature provides an initial source of parameter values for some of the reactions (7, 8) . Dissociation constants (K D ) for particular protein-protein interactions, where reported, were also obtained from the literature (1, 2) . In addition, MacBeath and coworkers have shown experimentally that these high-throughput measurements of protein-motif binding affinities predict the intracellular activation of proteins that interact directly with RTKs (i.e., upstream signaling events; ref. 26) . A discussion of the applicability of these in vitro derived values can be found in Supplementary Data. In addition, dissociation constants for reactions that create a cyclic pathway (e.g., reactions 10, 12, 16, and 17) were constrained by thermodynamic considerations. Initial conditions for ErbB1, insulin receptor substrate 1 (Irs-1), and protein tyrosine phosphatase (PTP) were specified during model calibration to be equal to 100, 10, and 100 nmol/L, respectively. The values for the remaining kinetic parameters and expression levels of Src homology 2 domain containing transforming protein 1 (Shc), growth factor receptor bound protein 2 (Grb2), and son of sevenless (Sos) were determined to be consistent with observed dynamic experimental data and tabulated in Supplementary Table S-V. A more detailed description of the specific calibration data used can be found in Supplementary Data.
Sensitivity Analysis and Model Validation
An important aspect of sensitivity analysis is to identify model parameters that can be uniquely determined from the available data. In other words, parameter identification analysis is a numerical technique that can be used to determine whether the parameter calibration problem is well posed. An a priori identifiability approach was used to select identifiable parameters given unlimited information about the modeled system (27) . A more detailed description of how this parameter identification approach was applied in developing the mathematical model can be found in Supplementary Data and ref. (28) . Subsequent analysis was restricted to the parameters that could be identified a priori.
Whereas it is common practice in the cell signaling literature to reuse parameters reported in other modeling studies, Green suggests that this approach may be ill-advised (29) . An empirical Bayesian approach was used to estimate the uncertainty of the model parameters given the calibration data and model structure (30) . The corresponding uncertainty associated with the model predictions was obtained by marginalizing the model predictions over the distribution in model parameters.
To estimate a threshold for primary receptor-protein interactions that correlate with cellular response, the simulated dose-dependent formation of protein-receptor complexes that lead to the activation of the Sos pathway was compared with experimentally observed dose-dependent proliferative response to EGF (31) . An increase in Ras-dependent mitogenic signaling pathways is a downstream consequence of activating the Sos pathway (32) and results in an increase in cell proliferation (33, 34) .
Estimating the Initial Conditions for Cellular Models of Breast Cancer
The objective of this study is to examine how differential expression of signaling proteins influences the topology of the signaling network by simulating the interaction of four signaling proteins: ErbB1, Shc, Grb2, and Irs-1. Initial conditions for the expression levels of these different signaling proteins were estimated based upon a comparative study among different breast cancer cell lines (19) . A more detailed description of how these data were used can be found in Supplementary Data.
Results and Discussion
Model calibration. Before investigating the potential for noncanonical signaling, the mathematical model, shown schematically in Fig. 1 , was calibrated and validated against values obtained from the literature. Parameter identification was used to limit the number of free parameters to only those parameters that can be uniquely determined from the calibration data (see Supplementary Table S-VI ). An empirical Bayesian approach was used to estimate the maximum expectation values for the model parameters given the available experimental data. The maximum expectation values for each of the parameters are shown in Supplementary Table S-V. In addition, the initial values for Grb2, Shc, and Sos were determined to be 261, 484, and 51.6 nmol/L, respectively. These values are dependent on base assumptions as the affinities for protein-protein interaction and concentrations of signaling proteins are correlated. However, similar results are obtained if the K D 's of protein-protein interactions reported by MacBeath and coworkers are systematically reduced by a factor of 10 (data not shown). In addition, the initial concentration of PTP was specified to be 100 nmol/L, as the initial concentration of PTP was confounded with other parameters (see Supplementary Table S-VI). As shown in Supplementary Fig. S3 , the simulated EGF-induced dynamic response of the initial signaling events showed good agreement with the experimental measurement of various components of the signaling network. More importantly, the simulated percentage of bound Sos, which integrates over both the ErbB1-Grb2 and the ErbB1-Shc-Grb2 pathways, showed good agreement with the data (see Supplementary Fig. S3E ).
An empirical Bayesian approach was also used to estimate the uncertainty associated with the model parameters given the available experimental data. The results from this approach suggest that the initial concentrations of Grb2, Shc, and Sos have a large influence on the model fitness, as shown by the narrow range in posterior density in Supplementary Fig. S4 . A similar observation was reported by Kholodenko and colleagues (8) and highlights the importance of studying how variations in protein expression influence cellular response. More importantly, the empirical Bayesian analysis also suggests that the values of Grb2, Shc, and Sos can be accurately estimated given the model and the calibration data.
Estimating an "importance" threshold. As mentioned above, the topology of a signaling network is described by a series of nodes and edges. Inclusions of an edge within a reaction network depend on whether an edge exceeds an "importance" threshold (35) or whether an edge is observed experimentally. The goal of this section was to estimate a threshold for multiprotein complex formation that correlates with cellular response, namely cell proliferation. To estimate this "importance" threshold, the dose-dependent formation of primary protein-receptor interactions that lead to the activation of the Sos pathway were compared against the response of a cell population to escalating doses of EGF. Activation of the Sos pathway increases Ras-dependent mitogenic signaling pathways, which are associated with an increase in cell proliferation. The primary protein-receptor interactions included Grb2 binding to ErbB1 (ErbB1-Grb2) and Shc binding directly to ErbB1 (ErbB1-Shc). Total ErbB1-Grb2 plus ErbB1-Shc at 60 minutes was simulated as a function of EGF dose. In Fig. 2 , the total ErbB1-Grb2 plus ErbB1-Shc is compared against the relative change in cell proliferation ("scaled cell growth"). In simulating these experiments, the initial level of expression of ErbB1 used in the simulations (100 nmol/L) was similar to the value (93 nmol/L) reported by Reddy and colleagues (31) . The distribution in sum of these two multiprotein complexes marginalized across the posterior distribution in parameter values exhibited a narrow distribution. Whereas the proliferation assay and simulations report results in different units, it is notable that the maximum in the formation of the ErbB1-Grb2 plus ErbB1-Shc complexes and cell proliferation corresponded to the same dose of EGF. The similar dosedependent behavior also provided a form of model validation, as it suggested that the biologically limiting mechanism in this system is associated with early signaling events. If downstream signaling events limited cell proliferation, the simulated maximum in these multiprotein complexes would have occurred at a higher dose of EGF than required for the observed maximum in cell proliferation.
An additional relationship was used to aid in interpreting the importance of noncanonical edges relative to canonical edges. As illustrated in Fig. 3A , the flow of information within intracellular signaling pathways has been described in terms of a cascade of activating (e.g., kinase action) and deactivating (e.g., phosphatase action) events that modify intermediate signaling proteins (36) . Within a level of this cascade, the steady-state activation of a signaling protein (A) is described by
ðAÞ where S2 is the total amount of signaling protein in both active (A) and inactive (I) conformations, RS1 is the amount of activating protein complex, D is the amount of deactivating protein, and ka and kd are the rate constants associated with activating and deactivating proteins, respectively (37) . Cellular response was assumed to be proportional to the abundance of A. Equation A was used to represent a signal-response relationship and to connect the output from the cue signal model (Fig. 1) to the cue-response data reported by Reddy and colleagues (31). In Fig. 3B , this signal-response relationship is compared with the observed scaled cell growth response, shown as a function of predicted ErbB1-Grb2 plus ErbB1-Shc complexes. As the amount of receptor complex decreases, the predicted proliferation response approaches zero. Note that observed cell growth is assumed to reflect the contributions of two independent pathways, as separate intracellular signals for regulating proliferation (i.e., the Ras pathway) and for regulating apoptosis (i.e., an implicit pathway) have been described (38) . Moreover, these two pathways may have different dose-dependent behavior. In Fig. 3B , the agreement between the predicted and observed scaled cell growth at a total complex concentration of 10 −0.5 suggests that EGF has little effect on cell proliferation and instead protects against apoptosis. However as the dose of EGF is decreased further, EGF is unable to protect against apoptosis, resulting in the observed negative values for scaled cell growth. The simplified signal-response relationship, described in Eq. A, was also used to interpret noncanonical edges. In short, the flow of signaling information is proportional to the formation of a multiprotein complex (i.e., an edge) and the ratio of deactivating/activating potential within this level (i.e., (kd × D)/ka). Thus, the formation of a noncanonical edge is a necessary, but not sufficient, condition for creating a (Fig. 1) relates a biochemical cue and intracellular signals. A single-level cascade was used to relate an intracellular signal to cellular response. B, the single-level cascade, as represented by Eq. A (line), is compared with changes in scaled cell growth, shown as a function of predicted total ErbB1-Grb2 plus ErbB1-Shc (circles).
novel branch in the signaling network of a cancer cell. To estimate the formation of a noncanonical branch, it was assumed that the activity (i.e., the ability to be posttranslationally modified) of a noncanonical edge was similar to a canonical edge. With respect to ErbB1-Irs-1 interaction, the amino acid sequence surrounding Irs-1-Tyr 896 (EPKSPGEYV-NIEFGS) ranked in the top 0.113% of potential substrates for the ErbB1 tyrosine kinase (6). Gaudet and colleagues also reported that only one known ErbB1 autophosphorylation site scored better than Irs-1-Tyr 896 (ErbB1-Tyr 1197 at 0.041%). In ideal MCA networks this is a common assumption, as the velocity of information flow associated with an edge is proportional only to the concentration of the effector enzyme that catalyzes the flow of information (9) . Effector enzymes in a metabolic network are equivalent to multiprotein signaling complexes (i.e., edges) in a signaling network. A reference point (i.e., a threshold) for edge abundance was established to assign biological significance to forming a noncanonical branch. A value of 1.0 nmol/L for the simulated redundant canonical edges, composed of total ErbB1-Grb2 plus ErbB1-Shc complexes, was considered biologically significant and corresponded to 30% of the maximal response in cell proliferation (dotted line in Fig. 2) . The empirical Bayesian analysis also showed that this threshold was tightly constrained given the model and the available data.
Influence of protein expression on the formation of noncanonical edges. Abnormal alterations in protein expression facilitate the oncogenic transformation of a normal cell into a cancer cell. Figure 4 illustrates the broad diversity in patterns of protein expression that exists among breast cancer cell lines. The variability in ErbB1 expression among cell lines spans over three orders of magnitude. Grb2 and Irs-1 expression also exhibit a similar wide variability in protein expression. In contrast, the combined expression of the p46 and p52 isoforms of Shc varies only by a factor of 10 among these cell lines. To estimate molar concentrations of the signaling proteins, the assays used for measuring the expression levels for Grb2, Shc, and Irs-1 were assumed to have the same sensitivity as the assay for ErbB1. The values for Grb2 and Shc obtained during model calibration were assigned to the lower end of the concentration ranges for estimated protein expression in these cell lines.
These observed patterns of protein expression were used to estimate the extent of formation of a noncanonical edge Figure 4 . Variability in protein expression among breast cancer cell lines. Estimated protein expression of canonical components (e.g., ErbB1, Shc, and Grb2) and a potential noncanonical (e.g., Irs-1) component of the ErbB1 signaling network vary significantly across various breast cancer cell lines (19) . The expression levels determined during model calibration are shown for comparison (dotted line).
resulting from the interaction of ErbB1 with Irs-1. In Fig. 5 , the edges corresponding to ErbB1-Shc, ErbB1-Grb2, and ErbB1-Irs-1 and the concentration of active ErbB1 that is unbound to any signaling protein were measured at 60 minutes following increasing doses of EGF. The extents of activation of these edges were simulated using initial conditions from three different cell lines: MCF-7 (A), 184A1N4 (B), and HCC1500 (C). The cell lines MCF-7, HCC1500, and 184A1N4 represented different extremes of protein expression. MCF-7 and HCC1500 both represented high basal expression, and 184A1N4 represented low basal expression of Irs-1. HCC1500
and 184A1N4 both represented high basal expression, and MCF-7 represented low basal expression of ErbB1. As is shown in all three panels, formation of the ErbB1-Irs-1 complex occurs to a different extent in all three cell lines. The noncanonical edge resulting from ErbB1-Irs-1 interaction exceeds the importance threshold in HCC1500 cells but does not exceed the threshold in MCF-7 and 184A1N4 cell lines.
A series of simulations were used to determine the range of protein expression levels that form the noncanonical edge: ErbB1-Irs-1. This sensitivity analysis was constrained to explore simultaneous variations in ErbB1 and Irs-1 expression (Fig. 4) are superimposed on the contour plots. In these simulations, the expression levels of Grb2, Shc, Sos, and PTP were fixed at 261, 484, 51.6, and 100 nmol/L, respectively. only. In Fig. 6 , formation of multiprotein complexes associated with the ErbB1-Shc (A), ErbB1-Grb2 (B), and ErbB1-Irs-1 (C) edges are shown as a function of ErbB1 and Irs-1 expression. The contour levels correspond to the initial dose of EGF required to form a specific edge above the defined threshold level (i.e., 1.0 nmol/L). Each point on the contour plot represents a point in three-dimensional space, where the three axes represent ErbB1 expression, Irs-1 expression, and EGF dose. Focusing on the right panel in Fig. 6 , the white regions in the bottom left portion of the graph correspond to regions of ErbB1-Irs-1 expression space that did not achieve the threshold level of edge formation at an initial dose of 32 nmol/L EGF. Cellular response in these regions was called insensitive to EGF. In the dark regions, activation of a particular signaling edge was achieved at the lowest dose of EGF (0.032 nmol/L). Cellular response in these regions was called hypersensitive to EGF. At such a low dose of EGF, autocrine production of EGF may be sufficient to maintain cell populations. Cellular responses in the insensitive and hypersensitive regions for the ErbB1-Shc and ErbB1-Grb2 edges were largely unchanged in response to variations in ErbB1 and Irs-1. The ErbB1-Shc and ErbB1-Grb2 edges transitioned from an insensitive region to a hypersensitive region in a narrow range of ErbB1 expression, whereas the transition was largely insensitive to changes in Irs-1 expression. The noncanonical ErbB1-Irs-1 edge also exhibited a transition from an insensitive region to a hypersensitive region. However, the transition region was dependent on both ErbB1 and Irs-1 expression. A high expression of Irs-1 was required to surpass the threshold for ErbB1-Irs-1 at low ErbB1 expression levels. As ErbB1 expression increased, the level of Irs-1 expression required to surpass the threshold for ErbB1-Irs-1 decreased.
The expression patterns in different cell lines from in vitro models of breast cancer were superimposed upon the contour plots to provide a disease context for the sensitivity analysis of edge formation. Three cell lines (MCF-7, 184A1N4, and HCC1500) were highlighted in the contour plot. Simulations suggested that 0.023 nmol/L of EGF was required to surmount the importance threshold for the ErbB1-Shc pathway in the MCF-7 cell line, a cell line with low basal expression of ErbB1. A higher concentration of EGF (0.4 nmol/L) was required to achieve the importance threshold for the ErbB1-Irs-1 pathway in the HCC1500 cell line. In the 184A1N4 cell line, expression of ErbB1 was sufficiently high, such that the cell line was in the hypersensitive range for the ErbB1-Shc and ErbB1-Grb2 edges. However, expression of ErbB1 was not sufficient to compensate for low expression of Irs-1. It was also interesting to note that many of the cell lines included in the analysis were clustered around the transition region between the insensitive and hypersensitive regions for the ErbB1-Irs-1 edge. Primary receptor-protein interactions that lead to canonical and noncanonical edges were also simulated using the initial conditions shown in Fig. 4 (see Supplementary Fig. S5 ). These results suggest that the HCC1500, HBL100, MCF10A, BT20, and BT474 breast cancer cell lines provide favorable conditions to observed noncanonical interactions between ErbB1 and Irs-1. In fact, Irs-1 promotes mammary tumorigenesis in the MCF10A cell model and in transgenic mice upon overexpression (39) . However, specific interaction between ErbB1 and Irs-1 was not reported.
Conclusions
Canonical pathways describe flow of information encoded by modification of intracellular signaling proteins. These canonical pathways allow one to map a particular cue (e.g., an increase in EGF) to the corresponding cellular response (e.g., an increase in cell proliferation). A noncanonical pathway refers to the flow of information down a novel branch, resulting in a different cellular response to a particular cue. A necessary, but not sufficient, condition for creating this novel branch is the formation of a noncanonical edge. The contribution of this work is to establish the plausibility of a noncanonical edge, given a mathematical model and the particular data used to calibrate this model. To achieve this aim, I have established a threshold for multiprotein complex formation that is correlated with cellular response (i.e., an "importance" threshold). In addition, I have shown that a noncanonical multiprotein complex, ErbB1-Irs1, surpasses this "importance" threshold in a subset of breast cancer cell lines. Taken together, the simulations presented support the concept that the topology of signal transduction networks within cells is influenced by quantitative parameters, such as protein expression and binding affinity. Moreover, the canonical pathway bias may mask molecular changes that give rise to oncogenic behavior. In the Biology of Cancer, Weinberg states that cancer cells and normal cells "use control circuitry that is almost identical. Cancer cells discover ways of making relatively minor modifications of the control machinery operating inside cells" (emphasis added; ref. 40) . In creating these minor modifications, cancer cells tweak existing controls that provide them with a selective advantage. It is in the study of these subtle differences in signaling circuitry, such as the formation of noncanonical edges, that will help us understand the mechanistic basis for cancer.
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